Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03849404
Recruitment Status : Recruiting
First Posted : February 21, 2019
Last Update Posted : June 11, 2019
Sponsor:
Information provided by (Responsible Party):
Alvotech Swiss AG

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2019
Estimated Study Completion Date : August 30, 2020